People between the ages of 18 and 65 who have been diagnosed with bipolar 1 and are currently in a depressive state are needed to participate in a clinical study.

The study is 11 weeks and includes eight total visits. At the completion, participants will be reimbursed $280 for time and travel.

We are testing the effects of a new investigational drug, Cariprazine, for bipolar depression. The study drug and psychiatric and physical assessments will be provided free of charge.

For more information, contact Nabila Lateef at 919-684-9701.